LRP5 and exudative vitreoretinopathy: Since patients with loss-of-function LRP5 variants may develop exudative vitreoretinopathy, a disease with a highly variability in phenotypic expression, we had anticipated that those with an LRP5 variant would have more DTCs opened for ophthalmology [14].